New antibody drug targets Hard-to-Treat cancers in early trial
NCT ID NCT07582822
First seen May 15, 2026 · Last updated May 20, 2026 · Updated 1 time
Summary
This early-stage study tests a new drug called JH021 in 60 people with advanced solid tumors that have stopped responding to standard treatments. JH021 is a special antibody designed to attack two cancer-related targets at once. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Henan Cancer Hospital
Zhengzhou, Henan, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hunan Cancer Hospital
Changsha, Hunan, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nanjing Tianyinshan Hospital
Nanjing, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Shanghai East Hospital
Shanghai, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai Pulmonary Hospital Affiliated to Tongji University
Shanghai, Shanghai Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Shanxi Cancer Hospital
Taiyuan, Shanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Yibin Second People's Hospital
Yibin, Sichuan, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.